The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 16, 2021
Filed:
Nov. 05, 2015
Applicant:
Optibiotix Limited, Yorkshire, GB;
Inventors:
Stephen Patrick O'Hara, Yorkshire, GB;
Sofia Kolida, Yorkshire, GB;
Assignee:
Optibiotix Limited, Yorkshire, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/702 (2006.01); A23L 33/21 (2016.01); A23L 2/52 (2006.01); A61K 35/747 (2015.01); A61K 45/06 (2006.01); A61K 35/741 (2015.01); A23L 29/269 (2016.01); A23L 33/135 (2016.01); A23L 33/26 (2016.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 49/00 (2006.01); C12Q 1/02 (2006.01); A23L 33/00 (2016.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61K 31/715 (2006.01);
U.S. Cl.
CPC ...
A61K 31/702 (2013.01); A23L 2/52 (2013.01); A23L 29/269 (2016.08); A23L 33/135 (2016.08); A23L 33/21 (2016.08); A23L 33/26 (2016.08); A23L 33/30 (2016.08); A61K 9/0053 (2013.01); A61K 9/50 (2013.01); A61K 31/715 (2013.01); A61K 35/741 (2013.01); A61K 35/747 (2013.01); A61K 45/06 (2013.01); A61K 49/0004 (2013.01); A61P 3/04 (2018.01); A61P 3/06 (2018.01); A61P 3/10 (2018.01); C12Q 1/025 (2013.01); A23V 2002/00 (2013.01); A23V 2200/00 (2013.01); A23V 2200/3202 (2013.01); A23V 2200/328 (2013.01); A23V 2200/3262 (2013.01); A23V 2200/332 (2013.01); A23Y 2220/00 (2013.01); A23Y 2220/35 (2013.01); A23Y 2220/71 (2013.01); G01N 2333/335 (2013.01); G01N 2333/938 (2013.01); G01N 2500/10 (2013.01);
Abstract
The present invention relates to a prebiotic composition comprising a galacto oligosaccharide (GOS) produced from, wherein the GOS acts as a selective growth medium for a chosenprobiotic bacterial strain, and wherein the GOS is substantially the same as the form produced by reverse β-galactosidase reaction in the chosen probiotic bacterial strain. The present invention also relates to methods of producing GOS and related composition incorporating the GOS.